Eytan Breman
Technik-/Wissenschafts-/F&E-Leiter bei CELYAD ONCOLOGY SA
Ursprung des Netzwerks ersten Grades von Eytan Breman
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 38 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Eytan Breman
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SOLVAY SA | Chemicals: Specialty | General Counsel | |
| RADIUS HEALTH, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| VOLCANO CORPORATION | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Virginia | College/University | Corporate Officer/Principal | |
| Wayne State University (Michigan) | College/University | Undergraduate Degree Undergraduate Degree | |
| DELHAIZE GROUP | Food Retail | General Counsel | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Corporate Officer/Principal | |
| University of Leeds | College/University | Doctorate Degree | |
| Yale University | College/University | Corporate Officer/Principal Doctorate Degree | |
| CBO TERRITORIA | Real Estate Development | Director/Board Member | |
| Ghent University | College/University | Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree | |
| Université Libre de Bruxelles | College/University | Graduate Degree Corporate Officer/Principal | |
| ICHEC | College/University | Graduate Degree Graduate Degree | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chief Executive Officer Director/Board Member | |
Linklaters de Bandt
 Linklaters de Bandt Miscellaneous Commercial ServicesCommercial Services Part of Linklaters LLP, Linklaters de Bandt is a Belgian company that provides legal services. The company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MedPole SA/NV | Chief Executive Officer Chief Operating Officer Director of Finance/CFO | ||
| Université Catholique de Louvain | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
DIAsource ImmunoAssays SA
 DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium. | Biotechnology | Director of Finance/CFO | |
| KITE PHARMA INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
ClubDeal SAS
 ClubDeal SAS Internet Software/ServicesTechnology Services Part of LVMH Moët Hennessy Louis Vuitton SE, ClubDeal SAS is a private club for long-term investors, specifically designed for multi-generational family offices, wealth funds, foundations, endowments, and private investors to exchange their most precious assets and invest together. The company is based in Paris, France. ClubDeal provides a trusted environment for its members, where they can share a wealth of knowledge, club deals, and projects in a fully trusted environment. The French company offers a wide spectrum of assets and business opportunities, peer-to-peer, from family to family, and collective wealth. Members confidently share accurate and transparent data in the comfort of absolute confidentiality, with no intermediary and no commissions. ClubDeal was acquired by Le Parisien Libéré SAS, part of LVMH Moët Hennessy Louis Vuitton SE on August 04, 2011. | Internet Software/Services | Director/Board Member | |
First Retail International NV
 First Retail International NV Miscellaneous Commercial ServicesCommercial Services Part of Parcofin SA, First Retail International NV is a Belgian company that provides business support and real estate credit services. The company is based in Dilbeek, Belgium. First Retail International was founded in 2012. | Miscellaneous Commercial Services | Director/Board Member | |
| Biological Manufacturing Services SA | Director/Board Member Director of Finance/CFO | ||
| Advanced Therapies Consulting Limited | Chief Executive Officer | ||
| Harvard Law School | College/University | Graduate Degree | |
| Université de Namur ASBL | College/University | Graduate Degree Graduate Degree | |
Stanley & Stella SA
 Stanley & Stella SA Apparel/Footwear RetailRetail Trade Stanley & Stella SA is a supplier of customizable blank textiles that helps in managing brands or creating promotional clothing. The private company is based in Auderghem, Belgium. The Belgian company produces and distributes wholesale eco-friendly premium garments that are sustainable and ethical. Stanley & Stella's new recycled collection and total look collection are worth discovering. The company was founded by Jean Chabert, who has been the CEO since incorporation. | Apparel/Footwear Retail | Director/Board Member | |
Medi-Market Group SA
 Medi-Market Group SA Internet RetailRetail Trade Medi-Market Group SA operates as a holding company with interests in the pharmaceutical industry. The company was founded by Yvan Verougstraete and is headquartered in Lasne, Belgium. | Internet Retail | Director/Board Member | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
| Nirvan Consultants LLC | President | ||
PetSerCo BV
 PetSerCo BV Financial ConglomeratesFinance PetSerCo BV operates as an investment vehicle. The company is headquartered in Wavre, Belgium. | Financial Conglomerates | Director/Board Member | |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Chairman | |
Partner Therapeutics, Inc.
 Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Biotechnology | Founder | |
Hendigo NV
 Hendigo NV Financial ConglomeratesFinance Hendigo NV is an investment holding Belgian company founded in 2013. The private company operates as an investment holding company. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Claris Clinic | Director/Board Member | ||
| LYELL IMMUNOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| INSTIL BIO, INC. | Biotechnology | Director/Board Member | |
T-Knife GmbH
 T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
Monopteros Therapeutics, Inc.
 Monopteros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Monopteros Therapeutics, Inc. manufactures pharmaceuticals. | Pharmaceuticals: Major | Director/Board Member | |
Appia Bio, Inc.
 Appia Bio, Inc. BiotechnologyHealth Technology Appia Bio, Inc. is an early stage biotechnology company based in an undisclosed location. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. The American company utilizes the biology of lymphocyte development with chimeric antigen receptor (CAR) and T cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-NKT) or gamma delta T cells from hematopoietic stem cells (HSCs) with its ACUA (Appia Cells Utilized for Allogeneic) technology platform. The ACUA platform was developed from groundbreaking research in the laboratory of Lili Yang, Ph.D., at the University of California, and collaboration with Appia Bio's other scientific founders, David Baltimore, Ph.D. at Caltech and Pin Wang, Ph.D. at the University of Southern California. The company was founded in 2020 by Jeffrey S. Wiezorek, David Baltimore, Jeenjoo Kang, Lili Yang, Edmund Kim, and Pin Wang. Jeenjoo Kang has been the CEO since 2020. | Biotechnology | Director/Board Member | |
Aniserco NV (Flemish Region)
 Aniserco NV (Flemish Region) Specialty StoresRetail Trade Aniserco NV is a private company based in Dilbeek, Belgium. Aniserco NV operates under the brand name Tom&Co, offering a wide range of high-quality pet products, including food, grooming accessories, toys, and litter, among others. The Belgian company provides a practical click & collect service and fast delivery to take care of pets. With trusted brand products and expert advice, Tom&Co is an ideal partner for pet owners to take care of their faithful companions. The company was founded in 1991, and Thierry Le Grelle has been the CEO of the company since 2022. | Specialty Stores | Director/Board Member | |
Nextgen Investment Group NV
 Nextgen Investment Group NV Financial ConglomeratesFinance Nextgen Investment Group NV is a private company headquartered in Watermael-Boitsfort, Belgium. The firm provides direct, indirect and real estate investments. It was founded in 2022. Jean-Marc Heynderickx is the current CEO of the company. | Financial Conglomerates | Chief Executive Officer |
Statistik
International
| Belgien | 25 |
| Vereinigte Staaten | 19 |
| Vereinigtes Königreich | 4 |
| Deutschland | 3 |
| Frankreich | 3 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 12 |
| Commercial Services | 5 |
| Retail Trade | 5 |
| Finance | 5 |
Operativ
| Director/Board Member | 103 |
| Corporate Officer/Principal | 58 |
| Chief Executive Officer | 32 |
| Chairman | 20 |
| Independent Dir/Board Member | 20 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jean-Marc Heynderickx | 22 |
| Michel Lussier | 20 |
| Serge Goblet | 20 |
| Debasish Francois Roychowdhury | 18 |
| Hilde Windels | 18 |
| Chris de Jonghe | 15 |
| Maria Koehler | 11 |
| Patrick Jeanmart | 10 |
| Charles Q. Morris | 10 |
| Margo Roberts | 10 |
| Philippe Dechamps | 10 |
| Stephen Rubino | 10 |
| Filippo Petti | 9 |
| Christian Homsy | 9 |
| Carri Duncan | 8 |
- Börse
- Insiders
- Eytan Breman
- Unternehmensverbindungen
